# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA676767 | F | Antiproliferative activity in Mouse mammary tumor FM3A | Mus musculus | 1 | ALA1133629 | cell-based format | Scientific Literature | |
2. | ALA676768 | F | Mammalian cell cytotoxicity assessed against mouse mammary tumor FM3A cells | Mus musculus | 26 | ALA1135896 | cell-based format | Scientific Literature | |
3. | ALA676769 | F | Cytotoxicity against FM3A mouse mammary cells | Mus musculus | 11 | ALA1145118 | cell-based format | Scientific Literature | |
4. | ALA676770 | F | Inhibitory activity against FM3A TK- cell line | Mus musculus | 6 | ALA1124895 | cell-based format | Scientific Literature | |
5. | ALA677834 | F | Inhibitory activity against FM3A TK- cell line; No data | Mus musculus | 2 | ALA1124895 | cell-based format | Scientific Literature | |
6. | ALA677835 | F | Compound was tested in vitro Antimalarial activity against Plasmodium berghei in infected mice (Mus musculus) administered intraperitoneally | Mus musculus | 1 | ALA1144928 | cell-based format | Scientific Literature | |
7. | ALA677836 | F | Compound was tested in vitro cytotoxicity against FM3A cell | Mus musculus | 9 | ALA1144928 | cell-based format | Scientific Literature | |
8. | ALA677837 | F | Inhibitory activity against mammalian FM3A cell | 2 | ALA1136352 | cell-based format | Scientific Literature | ||
9. | ALA677838 | F | Concentration required to cause a microscopically detectable alteration of normal cell morphology | Mus musculus | 8 | ALA1124895 | cell-based format | Scientific Literature | |
10. | ALA677839 | F | Cytotoxicity of compound was tested against mouse mammary tumor FM3A cells | Mus musculus | 10 | ALA1145969 | cell-based format | Scientific Literature | |
11. | ALA677840 | F | EC50 is the cytotoxic concentration of compound required to reduce FM3A (murine mammary carcinoma cells) cell viability by 50%. | Mus musculus | 5 | ALA1130413 | cell-based format | Scientific Literature | |
12. | ALA679609 | F | Antiviral and cytostatic effects againstTK-VZV virus expressed in FM3A cells | Mus musculus | 2 | ALA1129081 | cell-based format | Scientific Literature | |
13. | ALA679610 | F | Compound was tested for the inhibition of murine mammary carcinoma FM3A cell proliferation | Mus musculus | 4 | ALA1128337 | cell-based format | Scientific Literature | |
14. | ALA679611 | F | Cytostatic activity against murine mammary carcinoma FM3A cell line | Mus musculus | 11 | ALA1130322 | cell-based format | Scientific Literature | |
15. | ALA677918 | F | Evaluated in vitro for cytostatic activity against murine mammary carcinoma cells (FM3A) | Mus musculus | 2 | ALA1128776 | cell-based format | Scientific Literature | |
16. | ALA677919 | F | Inhibitory activity against proliferation of murine mammary carcinoma FM3A tumor cell line | Mus musculus | 10 | ALA1125784 | cell-based format | Scientific Literature | |
17. | ALA677920 | F | Inhibitory activity against proliferation of murine (FM3A) tumor cell. | Mus musculus | 5 | ALA1125784 | cell-based format | Scientific Literature | |
18. | ALA677921 | F | Inhibitory concentration required to inhibit murine mammary carcinoma FM3A cells proliferation | Mus musculus | 18 | ALA1149173 | cell-based format | Scientific Literature | |
19. | ALA677922 | F | In vitro antitumor activity against Murine mammary carcinoma (FM3A) cell lines. | Mus musculus | 8 | ALA1134545 | cell-based format | Scientific Literature | |
20. | ALA677923 | F | Tested for in vitro cytostatic activity against murine mammary carcinoma (FM3A) | Mus musculus | 10 | ALA1127375 | cell-based format | Scientific Literature |